SELLAS Life Sciences (SLS) Other Non Operating Income (2010 - 2019)
SELLAS Life Sciences (SLS) reported Other Non Operating Income of $668000.0 for Q4 2019, down 12.79% quarter-over-quarter from $766000.0 in Q3 2018.
SELLAS Life Sciences (SLS) Other Non Operating Income (2010 - 2019) Analysis & Trends
SELLAS Life Sciences (SLS) has 9 years of Other Non Operating Income data on file, last reported at $668000.0 in Q4 2019.
- Other Non Operating Income for Q4 2019 came in at $668000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $1.4 million (up 87.21% YoY), and the FY2020 annual result was $208000.0, down 68.86% from the prior year.
- Other Non Operating Income eased to $668000.0 in Q4 2019 per SLS's latest filing, from $766000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $766000.0 in Q3 2018 and troughed at -$321000.0 in Q1 2015.
- A 4-year average of $253285.7 and a median of $307000.0 in 2015 frame the typical range for Other Non Operating Income.
- On a YoY basis, Other Non Operating Income climbed as much as 116.9% in 2015 and fell as far as 94.55% in 2015.
- A 4-year view of Other Non Operating Income shows it stood at $440000.0 in 2015, then slumped by 138.64% to -$170000.0 in 2016, then surged by 550.59% to $766000.0 in 2018, then declined by 12.79% to $668000.0 in 2019.
- Business Quant data shows SLS's Other Non Operating Income at $668000.0 in Q4 2019, $766000.0 in Q3 2018, and -$170000.0 in Q1 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 668,000.00 |
| Sep 30, 2018 | 766,000.00 |
| Mar 31, 2016 | -170,000.00 |
| Dec 31, 2015 | 440,000.00 |
| Sep 30, 2015 | 307,000.00 |
| Jun 30, 2015 | 83,000.00 |
| Mar 31, 2015 | -321,000.00 |
| Dec 31, 2014 | 229,000.00 |
| Sep 30, 2014 | 597,000.00 |
| Jun 30, 2014 | -491,000.00 |
| Mar 31, 2014 | -165,000.00 |
| Dec 31, 2013 | 2.14 Mn |
| Sep 30, 2013 | 693,000.00 |
| Jun 30, 2013 | -70,000.00 |
| Mar 31, 2013 | -5.44 Mn |
| Dec 31, 2012 | 11.55 Mn |
| Sep 30, 2012 | -733,000.00 |
| Jun 30, 2012 | 5.93 Mn |
| Mar 31, 2012 | -18.27 Mn |
| Dec 31, 2011 | 7.36 Mn |